A molecular signature predictive of indolent prostate cancer

A molecular signature predictive of indolent prostate cancer

Many newly diagnosed prostate cancers present as low Gleason score tumors that require no treatment intervention. Distinguishing the many indolent tumors from the minority of lethal ones remains a major clinical challenge. We now show that low Gleason score prostate tumors can be distinguished as in...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Irshad, S, Bansal, M, Castillo-Martin, M, Zheng, T, Aytes, A, Wenske, S, Le Magnen, C, Guarnieri, P, Sumazin, P, Benson, M, Shen, M, Califano, A, Abate-Shen, C
Natura:	Journal article
Pubblicazione:	American Association for the Advancement of Science 2013

Documenti analoghi

Derivation and application of molecular signatures to prostate cancer: Opportunities and challenges
di: Doultsinos, D, et al.
Pubblicazione: (2021)

Partition coefficients of indoles and betacarbolines.
di: Guardado, P, et al.
Pubblicazione: (1997)

Indoles/
di: 244713 Houlihan, William J.
Pubblicazione: (1972)

Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
di: Wenske, S, et al.
Pubblicazione: (2009)

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution
di: Kasar, S., et al.
Pubblicazione: (2017)

Chemistry of indoles/
di: Sundberg, Richard J
Pubblicazione: (1970)

The nitration of indoles /
di: 433237 Smith, Lowell Richard

A gene signature associated with PTEN activation defines good prognosis intermediate risk prostate cancer cases
di: Ong, C, et al.
Pubblicazione: (2018)

The Molecular Taxonomy of Primary Prostate Cancer
di: Abeshouse, Adam, et al.
Pubblicazione: (2017)

The local molecular signature of human peripheral neuropathic pain
di: Sandy-Hindmarch, OP, et al.
Pubblicazione: (2024)

Subditine, a new monoterpenoid indole Alkaloid from bark of Nauclea subdita (Korth.) Steud. Induces apoptosis in human prostate cancer cells
di: Liew, S.Y., et al.
Pubblicazione: (2014)

The molecular staging of prostate cancer.
di: Yardy, G, et al.
Pubblicazione: (2005)

The molecular staging of prostate cancer.
di: Yardy, G, et al.
Pubblicazione: (2005)

Molecular oncology of prostate cancer /
di: Ross, Jeffrey S. (Jeffrey Stuart), 1945-, et al.
Pubblicazione: (2007)

Indolent Closure Creation
di: Strumpen, Volker
Pubblicazione: (2023)

Indoles. Part one
di: 244713 Houlihan, William J.

The fischer indole synthesis /
di: 321822 Robinson, Brian
Pubblicazione: (1982)

Molecular signature of star formation at high redshifts
di: Viti, S, et al.
Pubblicazione: (2008)

Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer
di: Yang, L, et al.
Pubblicazione: (2018)

Green oxidation of indoles using halide catalysis
di: Xu, Jun, et al.
Pubblicazione: (2022)

Spectroscopic analysis of intrinsic optical signature of dissolved ions in water
di: Ng, Yong Shen.
Pubblicazione: (2009)

Addition of indoles to oxyallyl cations for facile access to α-indole carbonyl compounds
di: Tang, Qiang, et al.
Pubblicazione: (2013)

Molecular signatures of T-cell inhibition in HIV-1 infection
di: Larsson, M., et al.
Pubblicazione: (2013)

1H-Indole-3-carbaldehyde azine
di: Rizal, M.R., et al.
Pubblicazione: (2008)

Molecular insights into substrate specificity of prostate specific antigen through structural modeling.
di: Singh, P, et al.
Pubblicazione: (2009)

NF-kappaB regulates androgen receptor expression and prostate cancer growth.
di: Zhang, L, et al.
Pubblicazione: (2009)

Palladium-catalysed N-annulation routes to indoles: the synthesis of indoles with sterically demanding N-substituents, including demethylasterriquinone A1.
di: Fletcher, A, et al.
Pubblicazione: (2007)

Towards derivation of a distinct signature permitting personalised treatment in prostate cancer
di: Lamb, A, et al.
Pubblicazione: (2013)

Towards derivation of a distinct signature permitting personalised treatment in prostate cancer
di: Lamb, A, et al.
Pubblicazione: (2012)

Ab initio calculations on indole-water, 1-methylindole-water and indole-(water)(2)
di: van Mourik, T, et al.
Pubblicazione: (2000)

Collaborative quantization embeddings for intra-subject prostate MR image registration
di: Shen, Z, et al.
Pubblicazione: (2022)

The molecular staging of prostate cancer [1]
di: Yardy, G, et al.
Pubblicazione: (2005)

Tandem palladium catalysis: New routes to indoles.
di: Willis, M, et al.
Pubblicazione: (2005)

Synthesis of new activated indoles
di: Perpustakaan UGM, i-lib
Pubblicazione: (2004)

Updates on molecular and biochemical development and progression of prostate cancer
di: Fahmy, Omar, et al.
Pubblicazione: (2021)

Spatial transcriptomic analysis of virtual prostate biopsy reveals confounding effect of tissue heterogeneity on genomic signatures
di: Figiel, S, et al.
Pubblicazione: (2023)

Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques
di: Langley, S, et al.
Pubblicazione: (2017)

1H-Indole-3-carbaldehyde thiosemicarbazone
di: Rizal, R.M., et al.
Pubblicazione: (2008)

Molecular signatures of neural connectivity in the olfactory cortex
di: Diodato, Assunta, et al.
Pubblicazione: (2016)

Berlusconi on trial: some lessons for judicial accountability.
di: Guarnieri, C
Pubblicazione: (2011)